SNPX
Income statement / Annual
Last year (2023), Synaptogenix, Inc.'s total revenue was $0.00,
and the percentage change from the previous year is not available.
In 2023, Synaptogenix, Inc.'s net income was -$6.04 M.
See Synaptogenix, Inc.,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
| Period Ended |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
| Operating Revenue |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
| Cost of Revenue |
$6,347.00
|
$5,714.00
|
$4,966.00
|
$4,872.00
|
$4,385.00
|
$2,999.00
|
| Gross Profit |
-$6,347.00
|
-$5,714.00
|
-$4,966.00
|
-$4,872.00
|
-$4,385.00
|
-$2,999.00
|
| Gross Profit Ratio |
0
|
0
|
0
|
0
|
0
|
0
|
| Research and Development Expenses |
$1.97 M
|
$6.32 M
|
$4.34 M
|
$3.07 M
|
$5.67 M
|
$4.89 M
|
| General & Administrative Expenses |
$6.34 M
|
$9.81 M
|
$8.28 M
|
$8.09 M
|
$9.84 M
|
$0.00
|
| Selling & Marketing Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General & Administrative Expenses |
$6.34 M
|
$9.81 M
|
$8.28 M
|
$8.09 M
|
$9.84 M
|
$6.26 M
|
| Other Expenses |
-$0.00
|
$0.00
|
$0.00
|
$28,362.00
|
$0.00
|
$0.00
|
| Operating Expenses |
$8.31 M
|
$16.13 M
|
$12.62 M
|
$11.16 M
|
$15.51 M
|
$11.15 M
|
| Cost And Expenses |
$8.31 M
|
$16.13 M
|
$12.62 M
|
$11.16 M
|
$15.51 M
|
$11.15 M
|
| Interest Income |
$1.65 M
|
$335,039.00
|
$7,110.00
|
$153,213.00
|
$378,707.00
|
$127,110.00
|
| Interest Expense |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Depreciation & Amortization |
$6,347.00
|
$5,714.00
|
$4,966.00
|
$4,872.00
|
$4,385.00
|
$2,999.00
|
| EBITDA |
-$8.31 M |
-$16.13 M |
-$12.61 M |
-$11.15 M |
-$15.51 M |
-$11.02 M |
| EBITDA Ratio |
0
|
0
|
0
|
0
|
0
|
0
|
| Operating Income Ratio |
0
|
0
|
0
|
0
|
0
|
0
|
| Total Other Income/Expenses Net |
$2.28 M
|
$10.56 M
|
$7,110.00
|
-$1.55 M
|
$378,706.00
|
$127,110.00
|
| Income Before Tax |
-$6.04 M
|
-$5.57 M
|
-$12.61 M
|
-$12.70 M
|
-$15.13 M
|
-$11.02 M
|
| Income Before Tax Ratio |
0
|
0
|
0
|
0
|
0
|
0
|
| Income Tax Expense |
$0.00
|
-$115,890.00
|
-$7,110.00
|
$1.55 M
|
-$378,707.00
|
$1.00
|
| Net Income |
-$6.04 M
|
-$5.46 M
|
-$12.60 M
|
-$14.25 M
|
-$14.76 M
|
-$11.02 M
|
| Net Income Ratio |
0
|
0
|
0
|
0
|
0
|
0
|
| EPS |
-29.56 |
-0.78 |
-2.51 |
-11.33 |
-2.48 |
-46.33 |
| EPS Diluted |
-29.56 |
-0.78 |
-2.51 |
-11.33 |
-2.48 |
-46.33 |
| Weighted Average Shares Out |
$466,076.00
|
$6.99 M
|
$5.02 M
|
$1.26 M
|
$5.95 M
|
$237,906.00
|
| Weighted Average Shares Out Diluted |
$466,076.00
|
$6.99 M
|
$5.02 M
|
$1.26 M
|
$5.95 M
|
$237,906.00
|
| Link |
|
|
|
|
|
|
